Manipal Health IPO: Rs 92.75B Fundraise Opens July 29

Manipal Health Enterprises is preparing to launch its Initial Public Offering, targeting a fundraise of Rs 92.75 billion. The book-built issue will open for subscription on July 29, 2026, with shares priced between Rs 560 and Rs 590 per share.

The IPO includes a fresh issue of Rs 80 billion and an Offer for Sale (OFS) of Rs 12.75 billion.

Investors can subscribe to the IPO from July 29, 2026, to July 31, 2026. The minimum investment for a lot size of 25 shares stands at Rs 14,750 at the upper price band.

Funds Allocation

Proceeds from the fresh issue are earmarked for specific purposes.

Rs 55.53 billion will repay borrowings of Manipal Hospitals Pvt Ltd.

Rs 5.74 billion is allocated for acquiring a minority stake in Sahyadri Hospitals Pvt Ltd.

Rs 18.73 billion will be utilized for general corporate purposes.

Selling shareholders in the OFS include promoters Imperius Healthcare Investments and Manipal Education and Medical Group India, alongside investors TPG SG Magazine and Novo Holdings Invest Asia.

Company Footprint & Financials

Established in 1991 by Dr. Ranjan Pai, Manipal Health Enterprises operates 49 hospitals. As of March 31, 2026, it managed 13,037 beds across 14 states and union territories.

This network positions it as one of India’s largest multispecialty hospital chains by bed capacity and facilities. The company focuses on specialties such as cardiac sciences, oncology, neurosciences, and gastro sciences.

Financially, Manipal Health Enterprises recorded consistent growth in revenue, EBITDA, and net worth from FY24 to FY26. However, net profit showed a slight decrease in FY26 compared to FY25.

Revenue generation occurs through direct patient payments, insurance, third-party administrators, government schemes, and corporate partnerships.

Risks Ahead

A significant reliance on insurance, third-party administrators, and government schemes for revenue poses a risk of payment delays, potentially impacting cash flows.

While the IPO aims to reduce debt, the company’s ongoing expansion plans could lead to increased debt levels in the future. Investors are advised to evaluate fundamentals, corporate governance, and valuations thoroughly, rather than relying solely on the brand name, before making investment decisions.